Keith E. Baer

727 total citations
17 papers, 473 citations indexed

About

Keith E. Baer is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Epidemiology. According to data from OpenAlex, Keith E. Baer has authored 17 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Small Animals and 4 papers in Epidemiology. Recurrent topics in Keith E. Baer's work include Veterinary Oncology Research (10 papers), Infectious Diseases and Mycology (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Keith E. Baer is often cited by papers focused on Veterinary Oncology Research (10 papers), Infectious Diseases and Mycology (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Keith E. Baer collaborates with scholars based in United States and United Kingdom. Keith E. Baer's co-authors include John D. Broussard, Sarah E. Evans, Jennifer J. Bonczynski, Philip J. Bergman, D. Craft, A. K. Patnaik, G. Neal Mauldin, Arthur I. Hurvitz, Steven R. Gilbertson and Richard J. Joseph and has published in prestigious journals such as Toxicology, Annals of Surgical Oncology and Journal of the American Veterinary Medical Association.

In The Last Decade

Keith E. Baer

16 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith E. Baer United States 13 291 103 99 74 64 17 473
Gina Μ. Michels United States 10 584 2.0× 394 3.8× 77 0.8× 20 0.3× 212 3.3× 16 856
Susanna Mueller Germany 10 69 0.2× 66 0.6× 281 2.8× 37 0.5× 16 0.3× 17 480
Gleidice Eunice Lavalle Brazil 14 496 1.7× 296 2.9× 78 0.8× 17 0.2× 102 1.6× 61 655
John H. Jardine United States 14 226 0.8× 30 0.3× 83 0.8× 33 0.4× 62 1.0× 44 568
Glen K. King United States 11 279 1.0× 103 1.0× 69 0.7× 8 0.1× 84 1.3× 16 511
Agnieszka Swierczak Australia 8 100 0.3× 34 0.3× 142 1.4× 32 0.4× 19 0.3× 11 660
Takuya Maruo Japan 11 118 0.4× 28 0.3× 37 0.4× 22 0.3× 67 1.0× 57 354
Seiichi Miwa Japan 15 248 0.9× 85 0.8× 70 0.7× 400 5.4× 26 0.4× 34 978
Tomohiro Sakakibara Japan 11 147 0.5× 21 0.2× 39 0.4× 69 0.9× 16 0.3× 33 398
Ali A. El‐Domeiri United States 11 113 0.4× 8 0.1× 218 2.2× 94 1.3× 22 0.3× 30 569

Countries citing papers authored by Keith E. Baer

Since Specialization
Citations

This map shows the geographic impact of Keith E. Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith E. Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith E. Baer more than expected).

Fields of papers citing papers by Keith E. Baer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith E. Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith E. Baer. The network helps show where Keith E. Baer may publish in the future.

Co-authorship network of co-authors of Keith E. Baer

This figure shows the co-authorship network connecting the top 25 collaborators of Keith E. Baer. A scholar is included among the top collaborators of Keith E. Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith E. Baer. Keith E. Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bergman, Philip J., et al.. (2008). Use of imiquimod 5% cream (Aldara™) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002–2005)*. Veterinary and Comparative Oncology. 6(1). 55–64. 37 indexed citations
2.
DiResta, Gene R., Sean W. Aiken, Philip J. Bergman, et al.. (2007). Use of an Artificial Lymphatic System During Carboplatin Infusion to Improve Canine Osteosarcoma Blood Flow and Clinical Response. Annals of Surgical Oncology. 14(8). 2411–2421. 4 indexed citations
3.
Evans, Sarah E., et al.. (2006). Comparison of endoscopic and full-thickness biopsy specimens for diagnosis of inflammatory bowel disease and alimentary tract lymphoma in cats. Journal of the American Veterinary Medical Association. 229(9). 1447–1450. 111 indexed citations
4.
Luong, Richard, Keith E. Baer, D. Craft, et al.. (2006). Prognostic Significance of Intratumoral Microvessel Density in Canine Soft-Tissue Sarcomas. Veterinary Pathology. 43(5). 622–631. 36 indexed citations
5.
Baer, Keith E.. (2006). Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis, Second Edition. American Journal of Dermatopathology. 28(4). 368–368. 1 indexed citations
6.
Dillon, Christopher J., G. Neal Mauldin, & Keith E. Baer. (2005). Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992–2000). Journal of the American Veterinary Medical Association. 227(12). 1955–1957. 17 indexed citations
7.
Bergman, Philip J., D. Craft, Keith E. Baer, et al.. (2004). Correlation of histologic grading of canine mast cell tumors with Ki67/PCNA/AgNOR/c‐Kit scores: 38 cases (2002–2003). Veterinary and Comparative Oncology. 2(2). 98–98. 5 indexed citations
8.
Broussard, John D., et al.. (2003). Feline Esophagitis Secondary to Gastroesophageal Reflux Disease: Clinical Signs and Radiographic, Endoscopic, and Histopathological Findings. Journal of the American Animal Hospital Association. 39(2). 161–167. 17 indexed citations
9.
Steiner, Jörg M., et al.. (2003). Use of a 13C-aminopyrine blood test: first clinical impressions.. PubMed. 67(3). 183–8. 27 indexed citations
10.
Ludwig, Lori, et al.. (2002). Use of thoracoscopy to determine the etiology of pleural effusion in dogs and cats: 18 cases (1998–2001). Journal of the American Veterinary Medical Association. 221(7). 990–994. 33 indexed citations
11.
Mauldin, G. Neal, et al.. (1999). Clinicopathologic features of dogs with hepatic microvascular dysplasia with and without portosystemic shunts: 42 cases (1991–1996). Journal of the American Veterinary Medical Association. 214(2). 218–220. 30 indexed citations
12.
Baer, Keith E., et al.. (1994). The use of computed tomography scan for the evaluation of orbital disease in cats and dogs.. Europe PMC (PubMed Central). 4(1). 24–30. 18 indexed citations
13.
Baer, Keith E., et al.. (1993). Multicentric Squamous Cell Carcinoma in situ Resembling Bowen's Disease in Cats. Veterinary Pathology. 30(6). 535–543. 39 indexed citations
14.
Baer, Keith E., et al.. (1991). Postnatal cerebellar cortical degeneration in Labrador Retriever puppies.. PubMed. 32(10). 619–21. 27 indexed citations
15.
Burk, Ronald L., Richard J. Joseph, & Keith E. Baer. (1990). SYSTEMIC ASPERGILLOSIS IN A CAT. Veterinary Radiology. 31(1). 26–28. 6 indexed citations
16.
Haschek, Wanda M., et al.. (1989). Effects of dimethyl sulfoxide (DMSO) on pulmonary fibrosis in rats and mice. Toxicology. 54(2). 197–205. 14 indexed citations
17.
Baer, Keith E., A. K. Patnaik, Steven R. Gilbertson, & Arthur I. Hurvitz. (1989). Cutaneous Plasmacytomas in Dogs: A Morphologic and Immunohistochemical Study. Veterinary Pathology. 26(3). 216–221. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026